Tradeshow
Apr 08, 2022
- Apr 14, 2022
New Orleans, LA | Booth #2018
Join us at American Association for Cancer Research (AACR) Annual Meeting 2022! Let’s talk about Thermo Fisher’s molecular technologies and workflows are revolutionizing our view of cancer.
We'll share the latest innovations in next generation cellular analysis, precise tumor profiling with digital PCR (dPCR), rapid next generation sequencing (NGS) for cancer variant analysis, and new microarray solutions for precision oncology. Learn about real time PCR(qPCR) solutions to accelerate molecular targets and therapeutic development too!
Jump to:
Print poster sessions | Poster listing & schedule |
AACR session category name | Poster # | Title/Presenter |
---|---|---|
Cancer Genomics 2 | 78 | Detection of gene fusions and exon skipping events in lung FFPE samples with Oncomine Precision Assay on Ion Torrent Genexus System Presenter: Amir Marcovitz |
Cancer Genomics 3 | 759 | Analytical performance of a novel next-generation sequencing assay for myeloid MRD Presenter: Wally Zhang |
Cancer Genomics 1 | 42 | High-throughput NGS solutions for detection of oncology variants, gene fusion events, and key oncology research endpoints Presenter: Dinesh Cyanam |
Cancer Genomics 1 | 764 | Fully automated sample-to-report NGS workflow for comprehensive genomic profiling of myeloid neoplasms Presenter: Sarah Brozio |
Genomic Instability 2 | 1515 | Shannon entropy of mutational signatures predicts sensitivity of signature detection in targeted sequencing |
Cancer Genomics 5 | 2940 | Somatic hypermutation analysis of chronic lymphocytic leukemia research samples by DNA or RNA input IGH chain sequencing Presenter: Michelle Toro |
Cancer Genomics 4 | 2293 | Evaluation of multiple myeloma research samples by analysis of multiple B cell receptor targets in a single NGS assay Presenter: Geoff Lowman |
Cancer Genomics 5 | 2944 | Rapid and accurate variant calling of FFPE samples with the Genexus System Presenter: Iris Casuga |
Cancer Genomics 5 | 2939 | Automation meets reliability: use of Oncomine Precision Assay on the Genexus System for accurate identification of cancer biomarkers in FFPE and liquid biopsy samples Presenter: Thilanka Jayaweeka |
New and featured products
For Research Use Only. Not for use in diagnostic procedures.